REGENCY: Obinutuzumab’s Promise for Lupus Nephritis
Join Dr Raquel Faria and Professors Richard Furie and Maria Dall’Era as they discuss the results of the phase 3 REGENCY trial of obinutuzumab for the treatment of lupus nephritis.This episode explores what obinutuzumab could mean for the future management of lupus nephritis. Disclaimer: During Lupus Academy podcast episodes, participants may refer to off label use of medicines forpatients with lupus. Lupus Academy does not make any recommendations about using a medicine outside the terms of its approved licence for use.
▶︎
Obinutuzumab in Lupus Nephritis - REGENCY - Prof. Dr. Brad Rovin, Prof. Dr. Ana Malvar
▶︎
Grand Rounds: Lupus Nephritis with Dr. Rovin
▶︎
Rethinking resuscitation decisions: R, DNR or clinician discretion?
▶︎
Episode 40: Theresa Wills: Teaching Math At a Distance
▶︎
Lupus Nephritis Treatment Trials- 2 Decades in 20 minutes
▶︎
The Patient at the Center: Understanding Value Based Care with Dr. Satya Sarma
▶︎
Deep Dive into LLMs like ChatGPT
▶︎
How To Read Your Lupus Lab Results Like a Pro! - Lupus Testing Masterclass
▶︎
Prof. Rovin on B-cell depletion in Lupus Nephritis
▶︎
My lupus diagnosis story
▶︎
What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service
▶︎
Episode 89: Jessica Ivy and Cat Maiorca: Judicious Use of AI in Math Teacher Education
▶︎
Autoimmune SIGNS Nobody Warns You About — And How Doctors Finally Connect the Dots
▶︎
Systemic Lupus Erythematosus (SLE) - signs and symptoms, pathophysiology, investigations, treatment
▶︎
How Senior Engineers Actually Build With AI in 2026 | Build a Full Stack Systems Architecture App
▶︎
The Most Famous (TV) Doctor Of All Time | Noah Wyle
▶︎
Think Faster, Talk Smarter with Matt Abrahams
▶︎
The Science & Treatment of Bipolar Disorder
▶︎
Lupus 2024 Year in Review: From CAR-T to Precision Therapies
▶︎